Nanda Singh
10Patents
3h-index
13Co-inventors
53Inventor score
Filing activity: Feb 27, 1998 → Aug 14, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6713300B1 | Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter | Human Necessities | 13 | Expired |
| US7670771B2 | Mutant sodium channel Nav1.7 nucleic acid methods | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6413719B1 | KCNQ2 and KCNQ3-potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies | Chemistry; Metallurgy | 3 | Expired |
| US7192579B2 | Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter | Human Necessities | 2 | Expired |
| US7141420B2 | Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter | Human Necessities | 1 | Expired |
| US8129353B2 | Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter | Human Necessities | 0 | Active |
| US9617316B2 | Mutant sodium channel Nav1.7 and methods related thereto | Chemistry; Metallurgy | 0 | Active |
| US9523127B2 | KCNQ2 and KCNQ3—potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies | Chemistry; Metallurgy | 0 | Active |
| US7214483B2 | KCNQ2 and KCNQ3—potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies | Chemistry; Metallurgy | 0 | Expired |
| US7189511B2 | Methods of screening and diagnostics using ATP-binding cassette transporter | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.